Exploring Axtria's Latest Incentive Compensation Benchmarking Studies
In the ever-evolving landscape of life sciences, optimizing incentive compensation strategies is pivotal for organizational success. Axtria has recently unveiled two comprehensive benchmarking studies aimed at enhancing the understanding of incentive compensation (IC) trends, crucial for life sciences organizations striving for excellence. These studies focus on both global and US markets and are tailored to provide actionable insights that can significantly boost sales team performance.
Key Trends and Insights Revealed
The Global (Ex-US) Incentive Compensation (IC) Benchmarking Study and the US Incentive Compensation Benchmarking Study present significant findings about how companies structure their incentive plans. By focusing on key trends, metrics, and best practices, these studies empower organizations to design effective incentive strategies that align with market demands.
Prevalence of Incentive Compensation Plan Types
One notable insight from the 2024 US Incentive Compensation Benchmarking Study is the prevalence of individual goal-based plans. These plans dominate the landscape for healthcare providers (HCP) and account teams. Interestingly, market access teams are increasingly incorporating Management by Objectives (MBOs) into their IC structures. This integration showcases a shift towards more strategic planning in incentive structures.
Data Metrics Utilization
The studies also shed light on the utilization of data metrics. For HCP teams, demand units remain the most common data metric. However, there is a significant transition observed in the use of net sales or revenue metrics, which dropped drastically from 25% in the previous year to only 12%. Conversely, account teams have adopted this metric more, with a rise from 18% to 36%. Such insights are critical for organizations to pivot their strategies based on the latest market dynamics.
Management by Objectives as a Driving Force
A standout feature of these studies is their exploration of MBOs. Approximately 40% of account teams and all market access teams have included MBO components in their incentive plans, demonstrating a strong alignment between organizational goals and individual performance. However, only a small percentage of HCP teams have adopted this approach, indicating a potential area for growth.
Incentive Compensation Pay Structures
A detailed look at pay structures reveals that oncology and rare disease incentive compensation plans offer higher earning potential for top performers. The average pay cap in these areas is notably higher, averaging 2.75x and 3.5x the target pay for oncology and rare disease, respectively. This highlights the necessity for life sciences organizations to create competitive IC plans that attract and retain top talent.
Global Perspectives from the Benchmarking Studies
The Global (Ex-US) Incentive Compensation Benchmarking Study complements the US study by focusing on broader trends that impact life sciences companies worldwide. Key areas of analysis include pay mixes, preferred incentive plan designs, and the effectiveness of different measurement methods. These insights can help organizations calibrate their IC programs to maximize engagement and effectiveness in various markets.
Strategies for Growth and Profitability
By leveraging the findings from these benchmarking studies, life sciences organizations can identify gaps in their current incentive plans. This enables them to adapt and innovate their compensation strategies, allowing for sustainable growth and improved team performance. The emphasis on continuous evaluation and adjustment is essential in this sector, where market conditions can shift rapidly.
About Axtria and Its Impact
Axtria is a leading global provider of cloud software and data analytics for the life sciences industry. The company collaborates with 16 of the top 20 life sciences companies, utilizing its deep industry expertise to drive digital transformations and enhance business outcomes. Axtria’s various products, including Axtria InsightsMAx™, SalesIQ™, and CustomerIQ™, are designed to help companies harness data effectively, driving informed decision-making across all levels of the organization.
Frequently Asked Questions
What is the purpose of Axtria's benchmarking studies?
These studies aim to provide insights into incentive compensation trends, helping organizations optimize their strategies for performance and growth.
How do MBOs factor into incentive compensation plans?
Management by Objectives (MBOs) are increasingly included in incentive plans to align individual performance with organizational goals, particularly in account and market access teams.
What trends are observed in data metrics used for compensation?
There has been a notable decline in the use of net sales metrics for HCP teams, while demand units have remained common, indicating shifts in how metrics drive compensation.
How can companies leverage these studies for growth?
By identifying strengths and gaps in their current plans, organizations can adjust their incentive strategies to better meet market needs and drive sales team effectiveness.
What role does Axtria play in the life sciences industry?
Axtria provides cloud software and data analytics solutions that empower life sciences companies to make data-driven decisions, enhancing patient outcomes and business performance.
